Inventor · disambiguated record
Jeffrey S. Wiezorek
Also filed as: WIEZOREK JEFFREY · WIEZOREK JEFFREY S · WIEZOREK JEFFREY SCOTT
5 granted patents·7 pending applications·104 citations·filing 2010–2025
81Inventor score
Top patents by PatentIndex Score
12 records- 0195US10322146B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2017·Granted Jun 18, 2019·17 cites·30 claims
- 0295US9855298B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2016·Granted Jan 2, 2018·80 cites·30 claims
- 0389US11779601B2Diagnostic methods for T cell therapyKITE PHARMA INC·Filed 2016·Granted Oct 10, 2023·5 cites·13 claims
- 0487US11491187B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2018·Granted Nov 8, 2022·2 cites·15 claims
- 0585US2025367221A1Methods of conditioning patients for t cell therapyKITE PHARMA INC·Filed 2025·Application pending·0 cites
- 0681US12458654B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·12 claims
- 0769US2024058381A1Methods of administering chimeric antigen receptor immunotherapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 0860US2023124097A1Engineering stem cell t cells with multiple t cell receptorsAPPIA BIO INC·Filed 2022·Application pending·0 cites
- 0958US2024240148A1Engineering stem cells for allogenic car t cell therapiesAPPIA BIO INC·Filed 2022·Application pending·0 cites
- 1056US2024271095A1Production of engineered t cells from stem cellsAPPIA BIO INC·Filed 2022·Application pending·0 cites
- 1151US2019151361A1Methods of administering chimeric antigen receptor immunotherapyKITE PHARMA INC·Filed 2018·Application pending·0 cites
- 1229US2012070432A1Treatment of pancreatic cancer using a dr5 agonist in combination with gemcitabineWIEZOREK JEFFREY SCOTT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey S. Wiezorek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →